iShares Biotechnology ETF Rating $123.22 -0.98 (-0.79%) Closing price 04:00 PM EasternExtended Trading$120.93 -2.29 (-1.86%) As of 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsBuy This Stock iShares Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy 2.70Holdings in IBB have an aggregate rating of Moderate Buy based on 801 analyst ratings issued in the past year covering 50 companies (83.7% of the portfolio).IBB Aggregate Price Target$123.22High Prediction$123.22Average Prediction$123.22Low Prediction$123.22Holdings in IBB have an aggregate price target of $123.22 and a range of $123.22 to $123.22 covering 50 companies (83.7% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy13 Buy rating(s)Moderate Buy28 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 IBB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.31%VRTXVertex Pharmaceuticals$493.84+0.3%4.0239 of 5 stars2.64$514.91 4.3%25Analyst ForecastAnalyst RevisionPositive News8.45%GILDGilead Sciences$103.17-2.8%4.5591 of 5 stars2.79$108.42 5.1%28Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionNews CoveragePositive NewsGap Down8.19%AMGNAmgen$280.84+0.4%4.647 of 5 stars2.43$310.57 10.6%23Upcoming EarningsAnalyst ForecastAnalyst RevisionPositive News7.32%REGNRegeneron Pharmaceuticals$602.64+0.5%4.7921 of 5 stars2.88$945.32 56.9%26Upcoming EarningsAnalyst ForecastAnalyst Revision3.54%ALNYAlnylam Pharmaceuticals$251.56+3.7%4.6055 of 5 stars2.77$315.58 25.5%26Upcoming EarningsAnalyst UpgradePositive News3.03%IQVIQVIA$150.38-0.2%4.9496 of 5 stars2.78$237.62 58.0%23Upcoming EarningsAnalyst DowngradePositive News2.96%ARGXargenx$614.76+2.4%3.4881 of 5 stars2.91$699.28 13.7%23News CoveragePositive News2.54%MTDMettler-Toledo International$1,062.52-1.2%3.6547 of 5 stars2.22$1,304.25 22.8%9Upcoming EarningsAnalyst ForecastNews CoveragePositive News2.34%WATWaters$337.96-0.8%4.0345 of 5 stars2.61$392.13 16.0%18Analyst ForecastNews Coverage2.24%NTRANatera$153.79-0.4%3.0015 of 5 stars3.00$175.76 14.3%16Insider TradeNews CoveragePositive News2.21%BNTXBioNTech$102.02-15.4%2.4959 of 5 stars2.89$143.44 40.6%18Analyst RevisionHigh Trading Volume2.03%BIIBBiogen$118.84-0.6%4.7629 of 5 stars2.42$211.37 77.9%31Upcoming EarningsAnalyst ForecastAnalyst RevisionNews Coverage1.62%ONCBeigene$244.90-4.4%3.1728 of 5 stars3.00$318.88 30.2%5Analyst ForecastNews Coverage1.53%UTHRUnited Therapeutics$291.38-1.7%4.923 of 5 stars2.67$390.17 33.9%12Upcoming EarningsAnalyst ForecastInsider TradePositive NewsGap Down1.48%INSMInsmed$69.69+1.1%4.1858 of 5 stars3.00$94.00 34.9%16Analyst ForecastOptions VolumeNews CoveragePositive NewsHigh Trading Volume1.42%ILMNIllumina$77.35-0.3%4.6199 of 5 stars2.48$138.70 79.3%211.38%BMRNBioMarin Pharmaceutical$63.30+0.9%4.8882 of 5 stars2.71$94.00 48.5%24Upcoming EarningsAnalyst Upgrade1.31%INCYIncyte$59.16+0.3%4.8654 of 5 stars2.21$74.69 26.2%19Upcoming Earnings1.18%EXELExelixis$37.43+0.6%4.3076 of 5 stars2.50$37.59 0.4%20Upcoming EarningsPositive News1.18%NBIXNeurocrine Biosciences$106.73+0.9%4.8187 of 5 stars2.86$161.14 51.0%22Upcoming EarningsAnalyst ForecastAnalyst RevisionNews Coverage1.10%GMABGenmab A/S$20.59+0.2%4.2328 of 5 stars2.69$39.17 90.2%13Analyst Revision1.07%MRNAModerna$27.22-0.6%4.3594 of 5 stars2.04$58.70 115.7%24Upcoming EarningsNews CoverageGap Down0.93%TECHBio-Techne$50.24-1.1%4.8262 of 5 stars2.38$81.14 61.5%8Upcoming Earnings0.88%RGENRepligen$144.75-0.3%4.554 of 5 stars2.57$176.82 22.2%14Upcoming EarningsNews Coverage0.86%MEDPMedpace$298.55-1.4%4.4338 of 5 stars2.23$349.30 17.0%13Earnings ReportAnalyst ForecastAnalyst Revision0.84%HALOHalozyme Therapeutics$60.49+2.1%4.4087 of 5 stars2.60$62.89 4.0%10Analyst ForecastNews Coverage0.78%ASNDAscendis Pharma A/S$164.15+2.3%2.3276 of 5 stars2.93$204.67 24.7%15Upcoming EarningsNews CoveragePositive News0.71%RVMDRevolution Medicines$38.77+0.5%3.8967 of 5 stars3.00$66.67 72.0%12Positive News0.68%MDGLMadrigal Pharmaceuticals$326.79+2.1%4.4857 of 5 stars3.00$409.00 25.2%9Analyst ForecastPositive News0.65%CRLCharles River Laboratories International$114.71-0.9%4.8647 of 5 stars1.94$182.00 58.7%16Gap Down0.64%BPMCBlueprint Medicines$87.66+1.8%2.6407 of 5 stars2.70$124.95 42.5%23Upcoming EarningsNews Coverage0.63%SRPTSarepta Therapeutics$60.44-2.1%4.6699 of 5 stars2.83$158.70 162.6%240.62%BBIOBridgeBio Pharma$36.31+1.0%4.5798 of 5 stars2.92$53.00 46.0%12Upcoming EarningsInsider TradePositive News0.58%ADMAADMA Biologics$21.86-2.1%1.9212 of 5 stars3.25$22.50 2.9%4Positive News0.56%ROIVRoivant Sciences$11.01+0.1%2.4207 of 5 stars3.00$17.50 58.9%4Insider TradeNews CoveragePositive NewsGap Up0.53%IONSIonis Pharmaceuticals$29.70+0.4%3.9726 of 5 stars2.70$56.72 91.0%20Upcoming Earnings0.52%CYTKCytokinetics$40.43+0.2%4.0034 of 5 stars2.94$79.13 95.7%18Analyst Forecast0.51%LEGNLegend Biotech$34.28+0.1%2.2168 of 5 stars2.92$78.82 129.9%12Analyst Forecast0.51%ALKSAlkermes$27.84+0.6%4.7891 of 5 stars2.67$38.50 38.3%12Upcoming EarningsNews CoveragePositive News0.49%AXSMAxsome Therapeutics$106.27+0.8%4.5796 of 5 stars3.00$169.80 59.8%16Positive News0.49%PCVXVaxcyte$32.92-4.6%3.1853 of 5 stars3.10$136.50 314.6%10Analyst ForecastAnalyst RevisionPositive News0.48%KRYSKrystal Biotech$168.06-0.6%4.7502 of 5 stars3.00$220.00 30.9%8News Coverage0.46%TEMTempus AI$52.90-1.1%1.6617 of 5 stars2.54$61.08 15.5%13Analyst Forecast0.46%BRKRBruker$39.07+0.3%4.8726 of 5 stars2.55$65.00 66.4%110.45%PTCTPTC Therapeutics$49.530.0%3.8661 of 5 stars2.53$63.92 29.1%15Analyst ForecastInsider TradeNews Coverage0.45%SMMTSummit Therapeutics$23.47-36.0%2.6535 of 5 stars3.00$36.70 56.4%10Upcoming EarningsAnalyst ForecastNews CoverageGap DownTrading HaltedHigh Trading Volume0.40%RYTMRhythm Pharmaceuticals$63.76+1.3%3.9019 of 5 stars3.00$74.92 17.5%13Positive News0.40%RNAAvidity Biosciences$30.84-0.3%2.3549 of 5 stars3.00$66.69 116.3%13Positive News0.38%RAREUltragenyx Pharmaceutical$38.09+1.2%4.4774 of 5 stars2.93$92.79 143.6%14Upcoming Earnings0.38%NUVLNuvalent$73.48-0.7%1.8385 of 5 stars2.90$115.50 57.2%10News CoveragePositive News This page (NASDAQ:IBB) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IBB Stock Free IBB Stock Alerts